Phibro Animal Health PAHC
NASDAQ PAHC
$34.45 -0.85 (-2.41%)
As of: Sep 17, 2026 · 3:59 PM EDT

Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026)

Phibro Animal Health (PAHC) posted Non-Current Assets of $565.7 million for Q2 2026, up 2.66% on a QoQ basis from $551.0 million in Q1 2026, and up 2.81% year-over-year from $550.3 million in Q2 2025.

Analysis

Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026) Analysis & Trends

Phibro Animal Health has reported Non-Current Assets for 14 years, with the latest figure at $565.7 million in Q2 2026.

  • On a quarterly basis, Non-Current Assets rose 2.81% year-over-year to $565.7 million in Q2 2026; TTM through Jun 2026 was $2.2 billion, a 9.05% increase from a year earlier, with the FY2026 full-year figure at $565.7 million, up 2.81% from the prior year.
  • Non-Current Assets was $565.7 million for Q2 2026 at Phibro Animal Health, up from $551.0 million in the prior quarter.
  • The five-year high for Non-Current Assets was $565.7 million in Q2 2026, with the low at $365.5 million in Q2 2022.
  • Average Non-Current Assets over 5 years is $445.8 million, with a median of $385.9 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets declined 1.16% in 2024, then surged 44.36% in 2025.
  • Over 5 years, Non-Current Assets stood at $380.1 million in 2022, then gained by 1.57% to $386.1 million in 2023, then jumped by 39.69% to $539.4 million in 2024, then gained by 0.74% to $543.4 million in 2025, then increased by 4.12% to $565.7 million in 2026.
  • The last three Non-Current Assets figures came in at $565.7 million (Q2 2026), $551.0 million (Q1 2026), and $543.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Idexx Laboratories 40.57 Bn 40.38 Bn 779.09 Mn 1.93 Bn
2 Zoetis 30.57 Bn 28.90 Bn 1.05 Bn 8.72 Bn
3 Elanco Animal Health 11.47 Bn 10.94 Bn 798.00 Mn 9.76 Bn
4 Phibro Animal Health 1.43 Bn 1.35 Bn 134.40 Mn 565.74 Mn
5 Immucell 87.38 Mn 78.52 Mn 2.44 Mn 25.55 Mn
6 Zhengye Biotechnology Holding 64.40 Mn 57.30 Mn - 42.16 Mn
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - 268,652.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 565.74 Mn
Mar 31, 2026 551.05 Mn
Dec 31, 2025 543.37 Mn
Sep 30, 2025 549.73 Mn
Jun 30, 2025 550.29 Mn
Mar 31, 2025 541.24 Mn
Dec 31, 2024 539.36 Mn
Sep 30, 2024 395.52 Mn
Jun 30, 2024 381.19 Mn
Mar 31, 2024 381.86 Mn
Dec 31, 2023 386.12 Mn
Sep 30, 2023 380.10 Mn
Jun 30, 2023 385.67 Mn
Mar 31, 2023 379.95 Mn
Dec 31, 2022 380.14 Mn
Sep 30, 2022 378.30 Mn
Jun 30, 2022 365.47 Mn
Mar 31, 2022 369.70 Mn
Dec 31, 2021 340.35 Mn
Sep 30, 2021 337.41 Mn